Window to Japan
According to reports from China, the cost of nuclear power in Japan is as low as to lead to a new energy mix for 2030 which will comprise 20 – 22 % of nucelear energy and a reduction of photovoltaic and other renewable energy sources to 22 – 24 %. China Bio news release, April […]
The center hosts presently 15.000 specimen obtained by biopsy and will provide extensive information on each sample in a FileMaker format. Nikkei Biotech news release, April 27, 2015
Regience will coopeerate with Hiroshi FUJIWARA at RIKEN CDB to produce hair follicles using 3D cultures of stem cells to reassemble functional hair follicles in vitro Regience news release, April 27, 2015
The effect is believed to be due to the pseudoestrogenic effect of soy isoflavones, and may help to stop degneration of knee cartilage in women after menopause, as shown by a rat model. Fujicco Co. news release, April 21, 2015
Takeda Pharmaceutical Co. has announced to have signed a 10 years’ joint collaborative research contract with Keio University school of medicine and Niigata University (Associate Prof. Masato YANO) to support Takeda’s research at Shonan Research Center with a focus on disease-related RNA-binding proteins. The application fields will be mostly CNS-related fields and oncology. Takeda news […]
Takeda Pharmaceuticals and Kyoto University’s CiRA announced that they will work together to develop clinical applications of induced pluripotent stem cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy. The “Takeda-CiRA Joint Program for iPS Cell Applications” (T-CiRA) is designed to expedite multiple research projects for drug discovery and cell […]
The system uses an oscillating water column type air turbine system with an air chamber“ which rotates the turbine
The groups of Hideki TANIGUCH at Saitama University and Takanori TAKEBE at Yokohama City University have developed a technology which allows the formation of organ buds from mesenchymal cells. As an example, 3D kidney tissue which produced urine and pancreatic tissue which has an insulin-controlling function were produced. JST news release April 17, 2015
The product ist he second regenerative medicine product registered in Japan. It is listed by health insurances and used fort he treatment of traumatic cartilage deficiency or osteochondritis dissecans in knee joints. Chondrocytes are harvested from the joint oft he patent, and with atelocollagen as scaffold expanded for 4 weeks, then transplanted by surgery. Sales […]
This new brand is claimed to suppress the absorption of fat from the diet and prevent the absorption of sugars. It will entert he market in June, 2015 Kirin news release, April 17, 2015